Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Indications: Body Mass Index (BMI) of 30 or Higher (Obesity)
But they also directly impact liver health
The clinical rationale for obesity treatment extends beyond cosmetic benefit to meaningful cardiovascular risk reduction: Wegovy's label now includes cardiovascular risk reduction in overweight adults, fundamentally altering the value proposition for payers [1]
Step 1: Insurance Verification Complete a brief health questionnaire detailing your insurance information
US$ 20.96
US$ 25.13
US$ 26.22
US$ 26.19
US$ 26.02
